NCT07139431View on ClinicalTrials.gov

A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 29, 2025

Primary Completion Date

March 6, 2026

Study Completion Date

April 21, 2028

Conditions
KOA
Interventions
BIOLOGICAL

NCR100

Subjects will receive a single injection of NCR100

Sponsors
All Listed Sponsors
lead

Nuwacell Biotechnologies Co., Ltd.

INDUSTRY

NCT07139431 - A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution | Biotech Hunter | Biotech Hunter